Prostate cancer: diagnosis and management

Status:	History
Publication date:	January 2014
Wave:	0
Process:	CG
Notes: This is an update of NICE Clinical guideline 58 (published February 2008)
Topic area: Cancer Urogenital

Project team | Schedule | Project history | Key documents

 

NICE project team

Centre for clinical practice lead:	Sharon Summers-Ma
Communications manager:	Alice Law
Guidelines commissioning manager:	Katie Perryman-Ford
Guidelines coordinator:	Anthony Gildea
Patient involvement lead:	Mandy Harling
Implementation lead:	Katie Perryman-Ford
Guidelines Development Group:	The Guideline Development Group (GDG) oversees the development process.

Top

Email enquiries

If you have any queries please email If you have any enquiries please email nice@nice.org.uk

Top

 

Provisional schedule

Scoping workshop:	11 November 2011
Consultation on draft scope with stakeholders:	28 November - 16 December 2011
Consultation on draft guideline with stakeholders:	16th July - 10th September 2013
Publication date:	January 2014

Top

 

Project history

Date   Update   8 January 2014 CG175 Prostate cancer (update of CG58) publishes   12 March 2012 The scope defines what aspects of care are covered by the guideline and to whom it applies. Comments that were made by stakeholders during the consultation on the scope can be seen in the scope consultation table. The Guideline Development Group (GDG) oversees the development process. 5 March 2012   In line with the draft methods for developing quality standards, the development of the quality standard will be the responsibility of a separate group.  This will include topics experts, some of whom will be drawn from the Guideline Development Group. The clinical guideline scope will form the basis from which the clinical guideline will be developed and the quality standard scope will inform the development of the quality standard, which will be developed following completion of the clinical guideline. 28 November 2011   The draft scope is out for consultation with stakeholders. The scope defines what aspects of care the guideline will cover and to whom it will apply. If you wish to comment, you need to do so via one of the registered stakeholder organisations listed, by the deadline shown.

Top

 

Key documents

Prostate cancer: guideline development and consultation 03 August 2012 Prostate cancer update: scoping workshop, consultation and final scope 12 March 2012 Prostate cancer update: list of registered stakeholders 19 November 2013 The Guideline Development Process - an overview for stakeholders, the public and the NHS 17 October 2011 Stakeholder registration 17 October 2011 NCC information 17 October 2011